FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119359965> ?p ?o ?g. }

• W3119359965 endingPage "1715" @default.
• W3119359965 startingPage "1706" @default.
• W3119359965 abstract "Abstract Background and purpose The potentially increased risk of extrathymic cancers in myasthenia gravis (MG) remains uncertain. We present the occurrence of extrathymic cancer diagnoses in different MG subgroups. Methods We conducted a nationwide Swedish register‐based cohort study, including patients who had their first MG diagnosis or first prescription of acetylcholine esterase inhibitors between the years 2006 and 2018. Timing and subtypes of cancer diagnosis in relation to MG as well as corticosteroid‐sparing immunosuppressants (CSISs) were identified from national patient, cancer and drug registers. Results In the study population of 2812 MG patients, 92 had juvenile MG (3%), 632 had early‐onset MG (23%), 1968 had late‐onset MG (LOMG; 70%) and 120 patients had thymoma‐associated MG (TAMG; 4%). Extrathymic cancers were observed in 630 patients (22.4%). Skin cancer and cancer in the male genital organs were most common ( N = 138, respectively), followed by cancers in the female genital organs ( N = 103), digestive organs ( N = 90) and breast ( N = 80). Patients with TAMG (29.2%) and LOMG (28.4%) had the highest occurrence of extrathymic cancer. Cancer frequency was comparable between acetylcholine receptor antibody seropositive and seronegative patients. Two or more CSIS prescriptions significantly increased the frequency of cancer, especially cancers in the digestive organs ( p = 0.0026), male genital organs ( p = 0.0037) and skin ( p < 0.0001). Conclusions Most extrathymic cancer types in MG were observed in TAMG and LOMG patients, and there was a clear correlation between CSIS exposure and cancer risk. This study sheds light on extrathymic cancers also in non‐thymoma MG." @default.
• W3119359965 created "2021-01-18" @default.
• W3119359965 creator A5024117218 @default.
• W3119359965 creator A5025026024 @default.
• W3119359965 creator A5064459555 @default.
• W3119359965 date "2021-01-28" @default.
• W3119359965 modified "2023-10-18" @default.
• W3119359965 title "Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: A Swedish nationwide register study" @default.
• W3119359965 cites W1897013744 @default.
• W3119359965 cites W1901725247 @default.
• W3119359965 cites W1910112204 @default.
• W3119359965 cites W1993459292 @default.
• W3119359965 cites W1997802276 @default.
• W3119359965 cites W1998731935 @default.
• W3119359965 cites W1999533993 @default.
• W3119359965 cites W2002275635 @default.
• W3119359965 cites W2014691590 @default.
• W3119359965 cites W2024763754 @default.
• W3119359965 cites W2025025945 @default.
• W3119359965 cites W2028924750 @default.
• W3119359965 cites W2046220600 @default.
• W3119359965 cites W2067350327 @default.
• W3119359965 cites W2074549036 @default.
• W3119359965 cites W2074926465 @default.
• W3119359965 cites W2078224934 @default.
• W3119359965 cites W2083985324 @default.
• W3119359965 cites W2089117937 @default.
• W3119359965 cites W2090253046 @default.
• W3119359965 cites W2099369381 @default.
• W3119359965 cites W2119043598 @default.
• W3119359965 cites W2120373771 @default.
• W3119359965 cites W2131756199 @default.
• W3119359965 cites W2143712834 @default.
• W3119359965 cites W2148298419 @default.
• W3119359965 cites W2155207266 @default.
• W3119359965 cites W2163768346 @default.
• W3119359965 cites W2166018731 @default.
• W3119359965 cites W2168021466 @default.
• W3119359965 cites W2203201709 @default.
• W3119359965 cites W2279973952 @default.
• W3119359965 cites W2340761814 @default.
• W3119359965 cites W2601155104 @default.
• W3119359965 cites W2740742967 @default.
• W3119359965 cites W2773276597 @default.
• W3119359965 cites W2780738432 @default.
• W3119359965 cites W2791800260 @default.
• W3119359965 cites W2794385223 @default.
• W3119359965 cites W316121240 @default.
• W3119359965 doi "https://doi.org/10.1111/ene.14730" @default.
• W3119359965 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33427389" @default.
• W3119359965 hasPublicationYear "2021" @default.
• W3119359965 type Work @default.
• W3119359965 sameAs 3119359965 @default.
• W3119359965 citedByCount "6" @default.
• W3119359965 countsByYear W31193599652021 @default.
• W3119359965 countsByYear W31193599652022 @default.
• W3119359965 countsByYear W31193599652023 @default.
• W3119359965 crossrefType "journal-article" @default.
• W3119359965 hasAuthorship W3119359965A5024117218 @default.
• W3119359965 hasAuthorship W3119359965A5025026024 @default.
• W3119359965 hasAuthorship W3119359965A5064459555 @default.
• W3119359965 hasBestOaLocation W31193599651 @default.
• W3119359965 hasConcept C121608353 @default.
• W3119359965 hasConcept C126322002 @default.
• W3119359965 hasConcept C143998085 @default.
• W3119359965 hasConcept C203014093 @default.
• W3119359965 hasConcept C2776349617 @default.
• W3119359965 hasConcept C2778105408 @default.
• W3119359965 hasConcept C2779159893 @default.
• W3119359965 hasConcept C2908647359 @default.
• W3119359965 hasConcept C530470458 @default.
• W3119359965 hasConcept C71924100 @default.
• W3119359965 hasConcept C90924648 @default.
• W3119359965 hasConcept C99454951 @default.
• W3119359965 hasConceptScore W3119359965C121608353 @default.
• W3119359965 hasConceptScore W3119359965C126322002 @default.
• W3119359965 hasConceptScore W3119359965C143998085 @default.
• W3119359965 hasConceptScore W3119359965C203014093 @default.
• W3119359965 hasConceptScore W3119359965C2776349617 @default.
• W3119359965 hasConceptScore W3119359965C2778105408 @default.
• W3119359965 hasConceptScore W3119359965C2779159893 @default.
• W3119359965 hasConceptScore W3119359965C2908647359 @default.
• W3119359965 hasConceptScore W3119359965C530470458 @default.
• W3119359965 hasConceptScore W3119359965C71924100 @default.
• W3119359965 hasConceptScore W3119359965C90924648 @default.
• W3119359965 hasConceptScore W3119359965C99454951 @default.
• W3119359965 hasFunder F4320322581 @default.
• W3119359965 hasIssue "5" @default.
• W3119359965 hasLocation W31193599651 @default.
• W3119359965 hasLocation W31193599652 @default.
• W3119359965 hasOpenAccess W3119359965 @default.
• W3119359965 hasPrimaryLocation W31193599651 @default.
• W3119359965 hasRelatedWork W163372931 @default.
• W3119359965 hasRelatedWork W1967901992 @default.
• W3119359965 hasRelatedWork W2013175739 @default.
• W3119359965 hasRelatedWork W2144332734 @default.
• W3119359965 hasRelatedWork W2154511406 @default.
• W3119359965 hasRelatedWork W2412093917 @default.

• next